Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERISAFE: Safety of ibuprofen after major orthopaedic surgeries
2022-502502-32-00Phase 4Completed
- Sponsor
- Slagelse Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute postoperative pain comparing Ibuprofen with Placebo (2 arms). Primary endpoint: Composite safety outcome within 90 days. Started Mar 2023; status: completed.
02
Drugs
ibuprofen
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2022-502502-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502502-32-00.